Chronic hepatitis B: Perceptions in Asian American communities and diagnosis and management practices among primary care physicians

Postgraduate Medicine

Volumn 122, Issue 5, 2010, Pages 165-175

  Upadhyaya, Nimit ^a   Chang, Robert ^a   Davis, Carol ^a   Conti, Molli C ^a   Salinas Garcia, Daniel ^a   Tang, Hong ^a  

^a BRISTOL MYERS SQUIBB   (United States)

Author keywords

Asian American; Diagnosis; Hepatitis B virus; Management; Perception; Primary care physicians

Indexed keywords

ADULT; AGED; ARTICLE; ASIAN; ASIAN AMERICAN; ATTITUDE TO ILLNESS; AWARENESS; BLOOD EXAMINATION; CHINESE; COMMUNITY; CONTROLLED STUDY; DISEASE COURSE; HEALTH CARE; HEALTH EDUCATION; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; INTERVIEW; KOREAN; PHYSICIAN ATTITUDE; PRACTICE GUIDELINE; PREVALENCE; PRIMARY MEDICAL CARE; PROPHYLAXIS; RANDOMIZATION; SCREENING; STRUCTURED QUESTIONNAIRE; TELEPHONE; UNITED STATES; VACCINATION; VIETNAMESE; ADOLESCENT; ATTITUDE TO HEALTH; BLOOD; CLINICAL COMPETENCE; CLINICAL PRACTICE; FEMALE; GENERAL PRACTITIONER; HEALTH PERSONNEL ATTITUDE; MALE; MIDDLE AGED; PRIMARY HEALTH CARE; QUESTIONNAIRE; STATISTICS;

HEPATITIS B ANTIBODY; HEPATITIS B ANTIGEN; HEPATITIS B VACCINE;

ADOLESCENT; ADULT; AGED; ASIAN AMERICANS; ATTITUDE OF HEALTH PERSONNEL; CLINICAL COMPETENCE; FEMALE; GUIDELINE ADHERENCE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEPATITIS B ANTIBODIES; HEPATITIS B ANTIGENS; HEPATITIS B VACCINES; HEPATITIS B, CHRONIC; HUMANS; INTERVIEWS AS TOPIC; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; PHYSICIANS, FAMILY; PRACTICE GUIDELINES AS TOPIC; PRIMARY HEALTH CARE; QUESTIONNAIRES; UNITED STATES;

EID: 78049495321     PISSN: 00325481     EISSN: 19419260     Source Type: Journal    
DOI: 10.3810/pgm.2010.09.2213     Document Type: Article

References (18)

1. Cohen C, Evans AA, London WT, Block J, Conti M, Block T. Underestimation of chronic hepatitis B virus infection in the United States of America. J Viral Hepat. 2008;15(1):12-13.
2. Lok AS, McMahon BJ. Chronic hepatitis B: update 2009. Hepatology. 2009;50(3):661-662.
3. Hann HW, Han SH, Block TM, et al. Symptomatology and health attitudes of chronic hepatitis B patients in the USA. J Viral Hepat. 2008;15(1):42-51.
4. Tran TT. Understanding cultural barriers in hepatitis B virus infection. Cleve Clin J Med. 2009;76(suppl 3):S10-S13.
5. Barnes PM, Adams PF, Powell-Griner E. Health characteristics of the Asian adult population: United States, 2004-2006. Adv Data. 2008;394:1-22.
6. Spiegel BM, Bolus R, Han S, et al. Development and validation of a disease-targeted quality of life instrument in chronic hepatitis B: the hepatitis B quality of life instrument, version 1.0. Hepatology. 2007;46(1):113-121.
7. Tsang T. Asian American Pacific Islander National Health Summit, September 14-16, 2006. http://liver.stanford.edu/Public/presentations/AAPIhealthsummit-NewYork-ThomasTsang.pps. Accessed January 10, 2010.
8. Synovate Healthcare. Hepatitis B Monitor Q1 2009, Syndicated Research Study. Philadelphia, PA; 2009.
9. Keeffe EB, Dieterich DT, Han SH, et al. A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: an update. Clin Gastroenterol Hepatol. 2006;4(8):936-962.
10. Chen CJ, Iloeje UH, Yang HI. Long-term outcomes in hepatitis B: the REVEAL-HBV study. Clin Liver Dis. 2007;11(4):797-816.
11. Straley SD, Terrault NA. Treatment of chronic hepatitis B. Curr Hepatitis Rep. 2003;2:49-59.
12. Chen HL, Chang MH, Ni YH, et al. Seroepidemiology of hepatitis B virus infection in children: ten years of mass vaccination in Taiwan. JAMA. 1996;276(11):906-908.
13. Wasley A, Kruszon-Moran D, Kuhnert W, et al. The prevalence of hepatitis B virus infection in the United States in the era of vaccination. J Infect Dis. 2010;202(2):192-201.
14. Chang TT, Lai CL, Kew Yoon S, et al. Entecavir treatment for up to 5 years in patients with hepatitis B e antigen-positive chronic hepatitis B. Hepatology. 2010;51(2):422-430.
15. Heathcote EJ, Gane EJ, De Man RA, et al. Three years of tenofovir disoproxil fumarate (TDF) treatment in HBeAg-positive patients with chronic hepatitis B (Study 103); preliminary analysis. AASLD 2009 Abstract 483. Hepatology. 2009;50:533A.
16. Marcellin P, Buti M, Krastev Z., et al. Three years of tenofovir disoproxil fumarate (TDF) treatment in HBeAg-negative patients with chronic hepatitis B (Study 102); preliminary analysis. AASLD 2009 Abstract 481. Hepatology. 2009;50:532A.
17. Centers for Disease Control and Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention. 2006 Disease Profile, 2008:49-55.
18. Centers for Disease Control and Prevention, Department of Health and Human Services. HIV/AIDS among Asians and Pacific Islanders 2008. http://www.cdc.gov/hiv/resources/factsheets/API.htm. Accessed August 2, 2010.